Impact of Cardiac Myosin Light Chain Kinase Gene Mutation on Development of Dilated Cardiomyopathy
Akihiko Hodatsu(Kanazawa University), Masakazu Yamagishi, Yoshihiro Asano(National Cerebral and Cardiovascular Center), Atsuko Imai‐Okazaki(The University of Osaka), Masa‐aki Kawashiri(Kanazawa University), Kenshi Hayashi(Kanazawa University), Osamu Tsukamoto(University of California, Los Angeles), Yuki Uyama(Ube Frontier University), Masafumi Kitakaze(Hanwa Memorial Hospital), Seiji Takashima(The University of Osaka), Tetsuo Konno(Kanazawa University), Noboru Fujino(Kanazawa University), Satoru Yamazaki(National Cerebral and Cardiovascular Center), Osamu Seguchi(National Cerebral and Cardiovascular Center)
Cited by 20
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
|Journal of Clinical Investigation|2010|440
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288